Hugh Murray (@hugh_murray_) 's Twitter Profile
Hugh Murray

@hugh_murray_

Advanced Trainee in Infectious Diseases | Running and hiking in my spare time

ID: 1112528172740800514

calendar_today01-04-2019 01:32:40

32 Tweet

89 Takipçi

116 Takip Edilen

Joaquin Moreno (@drjoaquinid) 's Twitter Profile Photo

👩🏻38. HIV since 2013. HAART since 2019. 3 months with fever, weight loss and cough Xpert MTB +. Pancytopenia Blood Smear (image) Diagnosis...

👩🏻38. HIV since 2013. HAART since 2019. 
3 months with fever, weight loss and cough
Xpert MTB +. Pancytopenia
Blood Smear (image)
Diagnosis...
Erin McCreary (@erinmccreary) 's Twitter Profile Photo

@emilylheil ACCP INFD PRN thank you @emilylheil for being funny and brilliant and sending me your slides in advance to help create this #tweetorial 🤗 #accpam19 #cap #idtwitter #medtwitter

Justin Denholm (@justin_denholm) 's Twitter Profile Photo

A good list Joshua Davis! I’ll point out that BRIEF TB used rifapentine rather than rifampicin, though, so we shouldn’t get too excited in Australia just yet. Sanofi when will you register here?

Justin Denholm (@justin_denholm) 's Twitter Profile Photo

Something of a change of pace from adult ID this week, as #VIDS_JC with Steven Tong looked at this really interesting article on microbiota-directed food supplements, presented by Dr Hugh Murray. 1/14 nejm.org/doi/full/10.10…

Steven Tong (@syctong) 's Twitter Profile Photo

Diagnostic codes for hospital discharges are important for lots of reasons. One being accuracy for burden of disease. Here we found that the rapidity of diagnostic test results (for flu) impacts on the discharge code: authors.elsevier.com/c/1hEge8nAo8s9… Nice work by trainee Hugh Murray

Paul Sax (@paulsaxmd) 's Twitter Profile Photo

REPRIEVE: Significant decrease in major adverse cardiovascular events with pitavastin. RCT trial enrolled only low-to-moderate CV risk PWH, for whom a statin might not otherwise be prescribed. Important clinical trial with direct relevance to pt care. nejm.org/doi/full/10.10…

REPRIEVE:  Significant decrease in major adverse cardiovascular events with pitavastin.

RCT trial enrolled only low-to-moderate CV risk PWH, for whom a statin might not otherwise be prescribed.

Important clinical trial with direct relevance to pt care. nejm.org/doi/full/10.10…